[Prevention of herpes simplex and varicella zoster infections in patients of HIV infections].
Reactivation of Herpes simplex virus and varicella zoster virus infections occurs frequently in patients infected with human immunodeficiency virus (HIV). Prevention of Herpes simplex recurrences with oral acyclovir (400 mg x 2/day) should be recommended for patients with more than 6 relapses per year. Varicella-zoster immunoglobulin is recommended for prophylaxis of varicella in exposed HIV-infected adults and children who are susceptible. Prevention of varicella-zoster recurrences with oral acyclovir (800 mg x 5/day) should be considered for patients with retinopathy.
Caumes
E
E
Service de Maladies Infectieuses et Tropicales, GH Pitié-Salpêtrière, Paris.
Bricaire
F
F
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control* / Q000628:therapy; D000328:Adult; D003586:Cytomegalovirus Infections / Q000517:prevention & control / Q000628:therapy; D006561:Herpes Simplex / Q000517:prevention & control* / Q000628:therapy; D006562:Herpes Zoster / Q000517:prevention & control* / Q000628:therapy; D006801:Humans; D008875:Middle Aged; D012307:Risk Factors
Prévention des infections par les virus Herpes simplex et varicelle-zona chez les patients infectés par le VIH.